Print this page
-
A Phase III Randomized Study of Maintenance Nivolumab versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPSCC.
Protocol: 032111Principal Investigator:
- Missak Haigentz MD (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Lip, Oral Cavity and Pharynx -
Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survivor Trial.
Protocol: 132004Principal Investigator:
- Sharon Manne PhD (Rutgers University)
Applicable Disease Sites: Lip, Oral Cavity and Pharynx
- 1
- 2